Pulse Biosciences, Inc.
52.97USD
+4.1800 (+8.57%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Operating Income | -25 | -19 | -18 | -20 | -20 | -18 | -20 | -14 |
| Net Income | -25 | -19 | -17 | -19 | -19 | -17 | -19 | -13 |
| EPS (Diluted) | — | — | — | — | — | — | — | — |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)